EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EGFR-Targeted Photodynamic Treatment of Triple Negative Breast Cancer Cell Lines Using Porphyrin–Peptide Conjugates: Synthesis and Mechanistic Insight

Miryam Chiara Malacarne iD, Federica Randisi iD, Emanuela Marras iD, Stefano Giovannardi iD, Paolo Dognini iD, Alan Mark Simm iD, Francesca Giuntini iD, Marzia Bruna Gariboldi iD, Enrico Caruso iD

Molecules · 29.08.2025 · 30 (17) · 3533

DOI: 10.3390/molecules30173533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 29.08.2025. Verfasst von Miryam Chiara Malacarne und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Life Sciences (DBSV), University of Insubria, Via J. H. Dunant 3, 21100 Varese, Italy. Hauptthemen laut MEDLINE: ErbB Receptors, Photochemotherapy, Triple Negative Breast Neoplasms, Porphyrins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, limiting the efficacy of conventional targeted therapies. As a result, novel therapeutic strategies are urgently needed. Photodynamic therapy (PDT), which relies on the activation of photosensitizers (PSs) by light to induce cytotoxic effects, has emerged as a promising alternative for TNBC treatment. Furthermore, the conjugation of PSs with targeting peptides has demonstrated enhanced selectivity and therapeutic efficacy, particularly for porphyrin-based photosensitizers. In this study, we report the synthesis of novel porphyrin–peptide conjugates designed to selectively target the epidermal growth factor receptor (EGFR), which is frequently overexpressed in TNBC. The conjugates were prepared via thiol displacement of the meso-nitro group in a 5,15-diarylporphyrin scaffold using EGFR-binding peptides. Photodynamic activity was evaluated in two EGFR-overexpressing TNBC cell lines. Cellular uptake of the conjugates correlated with EGFR expression levels, and PDT treatment resulted in differential induction of necrosis, apoptosis, and autophagy. Notably, the conjugates significantly inhibited EGFR-expressing cell line migration, a critical hallmark of metastatic progression. These findings underscore the potential of EGFR-targeted porphyrin–peptide conjugates as promising PDT agents for the treatment of TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErbB ReceptorsPhotochemotherapyTriple Negative Breast NeoplasmsPorphyrinsPhotosensitizing AgentsPeptidesHumansCell Line, TumorApoptosisFemaleCell ProliferationCell MovementAntineoplastic AgentsAutophagy

Stichwörter der Autor:innen

breast cancerdiarylporphyrinsepidermal growth factor receptor (EGFR)photodynamic therapy (PDT)therapeutic peptidetriple-negative breast cancer (TNBC)tumor targeting

Substanzen

ErbB ReceptorsPorphyrinsPhotosensitizing AgentsEGFR protein, humanPeptidesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biotechnology and Life Sciences (DBSV), University of Insubria, Via J. H. Dunant 3, 21100 Varese, Italy.
  • Centre for Neuroscience, Department of Biotechnology and Life Sciences (DBSV), University of Insubria, Via J. H. Dunant 3, 21100 Varese, Italy.
  • School of Pharmacy and Biomolecular Sciences, Byrom Street Campus, Liverpool John Moores University, Liverpool L3 3AF, UK.
  • Faculty of Sciences, Byrom Street Campus, Liverpool John Moores University, Liverpool L3 3AF, UK.

ORCID-Profile: Miryam Chiara Malacarne, Federica Randisi, Emanuela Marras, Stefano Giovannardi, Paolo Dognini, Alan Mark Simm, Francesca Giuntini, Marzia Bruna Gariboldi, Enrico Caruso

Zitieren

APA

Malacarne, M. C., Randisi, F., Marras, E., Giovannardi, S., Dognini, P., Simm, A. M., Giuntini, F., Gariboldi, M. B., & Caruso, E. (2025). EGFR-Targeted Photodynamic Treatment of Triple Negative Breast Cancer Cell Lines Using Porphyrin–Peptide Conjugates: Synthesis and Mechanistic Insight. Molecules, 30(17), 3533. https://doi.org/10.3390/molecules30173533

Vancouver

Malacarne MC, Randisi F, Marras E, Giovannardi S, Dognini P, Simm AM, et al. EGFR-Targeted Photodynamic Treatment of Triple Negative Breast Cancer Cell Lines Using Porphyrin–Peptide Conjugates: Synthesis and Mechanistic Insight. Molecules. 2025;30(17):3533. doi:10.3390/molecules30173533

BibTeX
@article{Malacarne2025,
  author = {Malacarne, Miryam Chiara and Randisi, Federica and Marras, Emanuela and Giovannardi, Stefano and Dognini, Paolo and Simm, Alan Mark and Giuntini, Francesca and Gariboldi, Marzia Bruna and Caruso, Enrico},
  title = {EGFR-Targeted Photodynamic Treatment of Triple Negative Breast Cancer Cell Lines Using Porphyrin–Peptide Conjugates: Synthesis and Mechanistic Insight},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {17},
  pages = {3533},
  doi = {10.3390/molecules30173533}
}
Kostenlos starten →